Hair loss in the tablet documents
Unlike most side effects of the tablet, hair loss has its own tablet figure in an official product document. The EU summary for Wegovy® tablets reports it from OASIS 4, the 64-week trial of the 25 mg tablet, and the sponsor’s posted results give the underlying counts. [2][3] The US label, which covers both forms, describes hair loss only from injection trials and states that the reactions in that part of section 6.1 apply to the injection and the tablet alike. [1]
| Source and trial | Wegovy® | Placebo | What else it says |
|---|---|---|---|
| EU product information, section 4.8, OASIS 4 [2] | 6.4% on the 25 mg tablet | 2.0% | all mild or moderate; half recovered by trial end; more often with ≥20% weight loss; rated “common” |
| ClinicalTrials.gov results, NCT05564117 [3] | 13 of 204 on the tablet (6.4%) | 2 of 102 (2.0%) | term “alopecia”, weeks 0–71; sponsor-entered |
| US label, section 6.1, injection 2.4 mg [1] | 3.3% (women 4%, men 0.9%) | 1% (women 2%, men 0) | associated with weight reduction; studies 2, 3 and 4 |
| US label, section 6.1, injection 7.2 mg [1] | 5.8% (women 8.4%, men 0.2%) | 1.0% | a few events led to dose reduction, a pause or stopping |
Why the tablet figure is higher than the injection one
The 6.4% from the tablet trial and the 3.3% from the injection trials are not a head-to-head comparison. They come from different studies with different people, and no trial has tested the tablet against the injection. [1][2] Two features of the tablet study are worth knowing when you read the numbers side by side.
First, the tablet trial was mostly women: 76% of the people who took part in the safety analysis were female. [1] In the injection data, where the label does split by sex, hair loss was reported by 4% of women and 0.9% of men on 2.4 mg, and by 8.4% of women against 0.2% of men on 7.2 mg. [1] The tablet documents give no split by sex, so it is not known how much of the higher tablet figure this explains.
Second, weight loss. In OASIS 4, average weight fell by 13.6% on the tablet against 2.2% on placebo at week 64, [4] and the EU summary reports hair loss more often in those who lost at least 20%. [2] A larger study of oral semaglutide at 50 mg once daily, OASIS 1, shows a similar picture in its posted results: alopecia in 6.9% against 2.7% on placebo. [5] That strength is not one of the Wegovy® tablet strengths in the US or EU documents (1.5, 4, 9 and 25 mg), so treat it only as supporting background. [1][2]
Severity, timing and recovery
The EU summary is reassuring on severity: no tablet case was rated severe, and half had recovered by the end of the trial, which ran for 64 weeks of treatment plus a seven-week follow-up. [1][2] The documents do not say when during the trial the shedding began, or how long it lasted in those who recovered.
For shedding triggered by a physical or emotional stress in general, known as telogen effluvium, MedlinePlus says you may not notice it for weeks to months after the trigger and that it decreases over six to eight months; it is usually temporary but can become long-term. [6] Cleveland Clinic places the start two to three months after the stressor, says that most short-lived cases resolve, and describes regrowth after the shedding phase. [7] These are general descriptions and were not measured in the tablet trial.
How weight loss and hair may be linked
- What the documents support: the US label links hair loss with weight reduction, and the EU summary found it more often with a loss of 20% or more. [1][2]
- A recognised general pathway: MedlinePlus lists crash diets, especially those short on protein, among the causes of telogen effluvium, and Cleveland Clinic names rapid weight loss and restrictive diets as triggers. [6][7] Neither source studied semaglutide.
- What is not shown: no Wegovy® document proposes a direct effect of semaglutide on hair follicles, and the trial data cannot separate the medicine from the weight loss it causes.
Other reasons hair can thin
MedlinePlus lists inherited pattern thinning, which increases with age, and shedding after childbirth, major surgery or illness, high fever or severe emotional stress. Some medicines can contribute, including retinoids, birth control pills, beta-blockers, calcium channel blockers, certain antidepressants and NSAIDs such as ibuprofen. [6]
Patchy or unusual loss suggests other causes: alopecia areata, anaemia, thyroid disease, hormone changes, autoimmune conditions, ringworm of the scalp, or hairstyles that pull hard on the roots. [6] These are reasons a clinician may want to examine the scalp or run blood tests rather than assume the tablet is responsible.
What general sources describe
For hair loss linked to illness or a medicine, MedlinePlus says no treatment is usually needed and hair generally grows back once the cause has passed; a wig, hat or new hairstyle can help in the meantime. [6] Cleveland Clinic stresses finding and addressing the underlying stressor, eating enough protein and avoiding extreme or restrictive diets, and asks you to check with a healthcare provider before starting any supplement. [7]
Two tablet-specific points apply to supplements. The Medication Guide asks you to tell your provider about all vitamins and herbal supplements, because Wegovy® slows stomach emptying, and the label asks for at least 30 minutes after the tablet before taking other oral medicines. [1] Your pharmacist can explain how a supplement fits into that morning routine.
Wegovy® is a registered trademark of Novo Nordisk A/S. PepLabo is not affiliated with or endorsed by Novo Nordisk.
When to get help
| Sign | Who to contact | How fast | Source |
|---|---|---|---|
| Hair loss with areas of infection on the scalp, or a scalp that is red, scaly, painful or itchy | Contact your provider | Today | MedlinePlus [6] |
| Nausea, vomiting or diarrhoea that will not settle, making it hard to eat or drink | Your prescriber the same day | Today | Medication Guide [1] |
| Bald patches, including on the beard or eyebrows, or hair loss in an unusual pattern | An appointment with your provider | At your next appointment | MedlinePlus [6] |
| Hair loss with tiredness, feeling cold, weight gain or muscle weakness | An appointment with your provider | At your next appointment | MedlinePlus [6] |
| Hair loss with acne, new facial hair or menstrual changes | An appointment with your provider | At your next appointment | MedlinePlus [6] |
| Shedding that bothers you or is still going on after several months | Your prescriber at the next visit | At your next appointment | Medication Guide [1]; Cleveland Clinic [7] |
